Moore Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $8.12M | Sell |
|
|||||
|
2025
Q2 | $10.5M | Buy |
|
|||||
|
2025
Q1 | $8.69M | Sell |
|
|||||
|
2024
Q4 | $10.3M | Hold |
|
|||||
|
2024
Q3 | $13.6M | Hold |
|
|||||
|
2024
Q2 | $10.1M | Buy |
|
|||||
|
2024
Q1 | $8.64M | Hold |
|
|||||
|
2023
Q4 | $8.85M | Buy |
|
|||||
|
2023
Q3 | $5.35M | Buy |
|
|||||
|
2023
Q2 | $4.84M | Buy |
|
|||||
|
2023
Q1 | $1.2M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $3.59M | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $2.17M | Buy |
|